Literature DB >> 29622596

Risk stratifying chest pain patients in the emergency department using HEART, GRACE and TIMI scores, with a single contemporary troponin result, to predict major adverse cardiac events.

Peter D W Reaney1, Hamish I Elliott2, Awsan Noman3, Jamie G Cooper1.   

Abstract

BACKGROUND: The majority of patients presenting to the ED with cardiac sounding chest pain have a non-diagnostic ECG and the problem of differentiating those suffering an acute coronary syndrome from those without is familiar to all ED clinical staff. To stratify risk in these patients, specific scores have been developed. Recent work has focused on incorporating newer high-sensitivity cardiac troponin (hs-cTn) assays; however, issues regarding performance and availability of these assays remain. AIM: Prospectively compare HEART, Global Registry of Acute Coronary Events (GRACE) and Thrombolysis in Myocardial Infarction (TIMI) scores, using a single contemporary cTn at admission, to predict a major adverse cardiac event (MACE) at 30 days.
METHOD: Prospective observational cohort study performed in a UK tertiary hospital in patients with suspected cardiac chest pain and no significant ST elevation on initial ECG. Data collection took place 2 December 2014 to 8 February 2016. The treating clinician recorded risk score data real time and a single contemporary cTn taken at presentation was used in score calculation. The primary endpoint was 30-day MACE. C-statistic was determined for each score and diagnostic characteristics of high-risk and low-risk cut-offs were calculated.
RESULTS: 189/1000 patients in the study developed a 30-day MACE. The c-statistic of HEART for 30-day MACE (0.87 (95% CI 0.84 to 0.90)) was higher than TIMI (0.78 (95% CI 0.74 to 0.81)) and GRACE (0.74 (95% CI 0.70 to 0.78)).HEART score ≤3 identified low-risk patients with sensitivity 99.5% (95% CI 97.1% to 99.9%) and negative predictive value (NPV) 99.6% (95% CI 97.3% to 99.9%) exceeding TIMI 0 (sensitivity 97.4% (95% CI 93.9% to 99.1%) and NPV 97.8% (95% CI 94.8% to 99.1%)) and GRACE score 0-55 (sensitivity 95.2% (95% CI 91.1% to 97.8%) and NPV 95.8% (95% CI 92.2% to 97.7%)).
CONCLUSION: HEART outperformed both TIMI and GRACE in overall discriminative capacity for 30-day MACE. Using a single contemporary cTn at presentation, a HEART score of ≤3 demonstrated sensitivity and NPV of ≥99.5% for 30-day MACE. These results reach the threshold for a safe discharge strategy but should be interpreted thoughtfully in light of other work. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  acute coronary syndrome; acute myocardial infarct; cardiac care, diagnosis; emergency department; risk management

Mesh:

Substances:

Year:  2018        PMID: 29622596     DOI: 10.1136/emermed-2017-207172

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  11 in total

1.  Modification of the HEART pathway by adding coronary computed tomography angiography for patients suspected of acute coronary syndrome in the emergency department.

Authors:  Yo Sep Shin; Shin Ahn; Youn-Jung Kim; Seung Mok Ryoo; Chang Hwan Sohn; Dong-Woo Seo; Won Young Kim
Journal:  Intern Emerg Med       Date:  2020-07-02       Impact factor: 3.397

2.  Indirect comparison of TIMI, HEART and GRACE for predicting major cardiovascular events in patients admitted to the emergency department with acute chest pain: a systematic review and meta-analysis.

Authors:  Jun Ke; Yiwei Chen; Xiaoping Wang; Zhiyong Wu; Feng Chen
Journal:  BMJ Open       Date:  2021-08-18       Impact factor: 3.006

3.  CHA2DS2-VASC Score Predicts Risk of Contrast-Induced Nephropathy in Non-ST Elevation Myocardial Infarction Patients Undergoing Percutaneous Coronary Interventions.

Authors:  Onur Baydar; Alparslan Kilic
Journal:  Kidney Dis (Basel)       Date:  2019-07-02

4.  Acute hyperglycemia and contrast-induced nephropathy in patients with non-ST elevation myocardial infarction.

Authors:  Onur Baydar; Alparslan Kilic
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-02-21

5.  Effectiveness of Modified HEART Score in Predicting Major Adverse Cardiac Events.

Authors:  Sultan Tuna Akgol Gur; Meryem Betos Kocak; Abdullah Osman Kocak; Mert Vural; Ilker Akbas; Sinem Dogruyol; Bugra Kerget; Zeynep Cakir
Journal:  Eurasian J Med       Date:  2021-02

6.  Heart rate n-variability (HRnV) and its application to risk stratification of chest pain patients in the emergency department.

Authors:  Nan Liu; Dagang Guo; Zhi Xiong Koh; Andrew Fu Wah Ho; Feng Xie; Takashi Tagami; Jeffrey Tadashi Sakamoto; Pin Pin Pek; Bibhas Chakraborty; Swee Han Lim; Jack Wei Chieh Tan; Marcus Eng Hock Ong
Journal:  BMC Cardiovasc Disord       Date:  2020-04-10       Impact factor: 2.298

7.  A retrospective HEART risk score comparation of acute non-traumatic chest pain patients in an emergency department in Spain.

Authors:  Iris Nathalie San Román Arispe; Josep Ramón Marsal Mora; Oriol Yuguero Torres; Marta Ortega Bravo
Journal:  Sci Rep       Date:  2021-12-01       Impact factor: 4.379

8.  Relationship between White Blood Count to Mean Platelet Volume Ratio and Clinical Outcomes and Severity of Coronary Artery Disease in Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Altekin Refik Emre; Kilinc Ali Yasar; Yanikoglu Atakan; Cicekcibasi Orhan; Kucuk Murathan
Journal:  Cardiovasc Ther       Date:  2020-08-13       Impact factor: 3.023

9.  Evaluation and comparison of six GRACE models for the stratification of undifferentiated chest pain in the emergency department.

Authors:  Wen Zheng; Guangmei Wang; Jingjing Ma; Shuo Wu; He Zhang; Jiaqi Zheng; Feng Xu; Jiali Wang; Yuguo Chen
Journal:  BMC Cardiovasc Disord       Date:  2020-04-25       Impact factor: 2.298

10.  Real-time AI prediction for major adverse cardiac events in emergency department patients with chest pain.

Authors:  Pei-I Zhang; Chien-Chin Hsu; Yuan Kao; Chia-Jung Chen; Ya-Wei Kuo; Shu-Lien Hsu; Tzu-Lan Liu; Hung-Jung Lin; Jhi-Joung Wang; Chung-Feng Liu; Chien-Cheng Huang
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2020-09-11       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.